Endovascular Neural Interface

Endovascular Neural Interface — clinically exemplified by the stent-electrode recording array (Stentrode) — is a minimally invasive Brain–Computer Interface and motor Neuroprosthetics platform implanted into intracranial blood vessels via percutaneous catheter navigation rather than open cranial neurosurgery. Pioneered by interventional neurologist Thomas J. Oxley, biomedical engineer Nicholas L. Opie, and colleagues at the University of Melbourne (2016) and translated to first-in-human paralysis trials in Australia and the United States (2020–2023), endovascular neural engineering uses the cerebrovenous drainage network as a natural anatomical conduit to the cerebral cortex. Deploying a self-expanding nitinol scaffold populated with microelectrodes inside the superior sagittal sinus adjacent to bilateral primary motor cortex enables chronic recording of broadband vascular field potentials without craniotomy, burr holes, dural incision, or direct penetration of brain parenchyma.

The Superior Sagittal Sinus Corridor to Primary Motor Cortex

Along the dorsal midline of the cranial vault, the superior sagittal sinus (SSS) courses within the attached margin of the dural falx cerebri, draining superficial cortical veins posteriorly toward the confluence of sinuses, transverse and sigmoid sinuses, and internal jugular veins. Over the posterior frontal lobe, the floor and lateral walls of the SSS lie within 1.0 to 2.5 mm of the medial and dorsomedial precentral gyrus (primary motor cortex, Brodmann area 4)—encompassing the lower-limb motor representation in the interhemispheric fissure and adjacent upper-limb territories.

Implantation adapts standard neurointerventional venous-stenting workflows practiced in stroke and idiopathic intracranial hypertension centers:

1. Preoperative Venographic and Functional Mapping: Contrast magnetic resonance or computed tomography venography measures SSS lumen diameter (4 to 8 mm over motor cortex) and maps bridging cortical veins (such as the vein of Trolard) to avoid obstructing cortical outflow, while functional MRI during attempted movement localizes target motor segments.
2. Transjugular Coaxial Catheter Navigation: Under biplane digital subtraction road-mapping angiography, ultrasound-guided venipuncture of the internal jugular vein in the neck permits retrograde advancement of coaxial guidewires and 4-French to 6-French microcatheters through the sigmoid and transverse sinuses into the target SSS segment.
3. Self-Expanding Deployment and Chest Tunneling: Retracting the delivery sheath expands the stent-electrode scaffold against the sinus wall. A flexible insulated intravascular micro-lead exits the jugular venotomy and tunnels subcutaneously over the clavicle to a hermetically sealed implantable receiver–telemetry unit (ITU) inside an infraclavicular chest pocket—mirroring cardiac pacemaker implantation and allowing hospital discharge within 24–48 hours.

Superelastic Nitinol Incorporation and Antiplatelet Management

An endovascular recording array mounts 8 to 16 laser-welded platinum or platinum–iridium disk electrodes (500–750 μm diameter, 2–4 mm spacing) onto the outer crowns of a braided or laser-cut nitinol (nickel–titanium) venous stent. Nitinol's superelasticity maintains gentle radial apposition across tapered venous lumens while accommodating neck motion and cardiorespiratory pulsatility without fatigue fracture.

Chronic biointegration relies on neo-endothelialization. Within 1 to 4 weeks post-deployment—quantified via synchrotron micro-CT and histology in ovine cortex (Oxley et al., 2016)—luminal endothelial cells and vascular smooth-muscle cells proliferate over the nitinol struts. Within one month, the recording disks become embedded inside the fibrous venous wall, insulated from luminal blood flow and pressed against the abluminal dural-cortical boundary.

Because the scaffold never breaches the Blood-Brain Barrier or enters parenchyma, it avoids intraparenchymal microhemorrhage and chronic foreign-body encapsulation by reactive Microglia and hypertrophic Astrocyte sheaths that attenuate single-unit recordings around penetrating Microelectrode Array shanks. Clinical safety management instead targets venous hemodynamics: because bare metal struts in low-velocity venous blood are transiently prothrombotic before endothelialization completes, recipients take dual antiplatelet prophylaxis (oral aspirin plus clopidogrel, verified via P2Y12 platelet assays) for at least 3 months, transitioning to lifelong low-dose aspirin alongside serial CT venograms confirming sinus patency and absence of venous stenosis.

Spectral Bandwidth and Spatial Resolution Relative to ECoG and EEG

Scalp Electroencephalography (EEG) suffers spatial smearing (~20–50 mm) and low-pass filtering because cranial bone has ~20–80 times higher electrical resistivity than cortex, obscuring focal high-gamma (70–200 Hz) activity beneath thermal and scalp Electromyography noise. Positioned beneath the skull, an endothelialized stent-electrode bypasses cranial bone attenuation.

Simultaneous recordings from endovascular SSS arrays, subdural grids, and epidural strips in sheep (John et al., 2018) demonstrated that vascular electrocorticography (vECoG) achieves signal-to-noise ratios and spatial resolution (~2.4 to 4.0 mm) comparable to subdural and epidural Electrocorticography across Local Field Potential rhythms up to ~200 Hz—capturing movement-related mu (8–12 Hz) and beta (13–30 Hz) event-related desynchronization alongside spatially focal high-gamma (70–200 Hz) population bursts, while also supporting focal transvascular motor cortex stimulation across the sinus wall (Opie et al., 2018).

First-in-human testing of a wireless endovascular motor neuroprosthesis began in the Australian SWITCH trial (Stentrode With Thought-Controlled Digital Switch; Oxley et al., 2021; Mitchell et al., 2023) enrolling four patients with bilateral upper-limb paralysis from amyotrophic lateral sclerosis (ALS) or primary lateral sclerosis, followed by the six-patient U.S. FDA Investigational Device Exemption COMMAND study.

In SWITCH, a 16-contact SSS Stentrode transmitted 1–200 Hz vECoG telemetry wirelessly via the chest ITU to a tablet computer. Machine-learning Neural Decoding classifiers translated attempted movement patterns into discrete digital click and zoom switches (~92%–94% accuracy) paired with eye-tracking cursor navigation. Across 12 months of independent home use, all four participants performed texting, email, online shopping, and personal finance at 14 to 20 characters per minute with zero device-related serious adverse events, zero target-vessel thrombosis or occlusion, and stable multi-month decoding—establishing endovascular interfaces as a practical clinical option for paralyzed patients who wish to avoid open craniotomy.

Can endovascular electrodes reach lateral cortical areas outside the midline sagittal sinus?

The superior sagittal sinus trunk primarily overlies medial lower-limb, supplementary motor, and visual cortices. Accessing lateral hand-knob or ventral speech motor cortex requires sub-millimeter flexible polymer or nanowire microcatheter electrodes engineered to navigate narrower branching cortical veins (such as the central sulcus vein of Roland or vein of Trolard).

Why does vECoG signal quality stabilize over the first four weeks post-implant?

At initial deployment, bare electrodes contact flowing venous blood that partially shunts cortical potentials and transmits cardiac pulse artifacts. As neo-endothelial tissue incorporates the stent over days 7 to 28, the vessel wall insulates contacts from luminal blood and secures them against the dural-cortical boundary, stabilizing impedance and high-gamma SNR.

1. Oxley, T. J., Opie, N. L., John, S. E., Rind, G. S., Ronayne, S. M., Wheeler, T. L., Judy, J. W., McDonald, A. J., Dornom, A., Lovell, T. J. H., Steward, C., Garrett, D. J., Moffat, B. A., Lui, E. H., Yassi, N., Campbell, B. C. V., Wong, Y. T., Fox, K. E., Nurse, E. S., Bennett, I. E., Bauquier, S. H., Liyanage, K. A., van der Poel, N. R., Desai, M. A., O'Brien, T. J., & May, C. N. (2016). Minimally invasive endovascular stent-electrode array for high-fidelity, chronic recordings of cortical neural activity. Nature Biotechnology, 34(3), 320–327. https://doi.org/10.1038/nbt.3428
2. John, S. E., Opie, N. L., Wong, Y. T., Rind, G. S., Ronayne, S. M., Gerboni, G., Bauquier, S. H., O'Brien, T. J., May, C. N., Grayden, D. B., & Oxley, T. J. (2018). Signal quality of simultaneously recorded endovascular, subdural and epidural signals are comparable. Scientific Reports, 8, 8427. https://doi.org/10.1038/s41598-018-26457-7
3. Opie, N. L., John, S. E., Rind, G. S., Ronayne, S. M., Wong, Y. T., Gerboni, G., Yoo, P. E., Lovell, T. J. H., Scordas, T. C., Wilson, S. L., Dornom, A., Vale, T., O'Brien, T. J., Grayden, D. B., May, C. N., & Oxley, T. J. (2018). Focal stimulation of the sheep motor cortex with a chronically implanted minimally invasive electrode array mounted on an endovascular stent. Nature Biomedical Engineering, 2(12), 907–914. https://doi.org/10.1038/s41551-018-0321-z
4. Oxley, T. J., Yoo, P. E., Rind, G. S., Ronayne, S. M., Lee, C. M. S., Bird, C., Hampshire, V., Sharma, R. P., Morokoff, A., Williams, D. L., MacIsaac, C., Howard, M. E., Irving, L., Vrljic, I., Williams, C., John, S. E., Weiser, F., Opie, N. L., & Mitchell, P. (2021). Motor neuroprosthesis implanted with neurointerventional surgery improves capacity for activities of daily living tasks in severe paralysis: first in-human experience. Journal of NeuroInterventional Surgery, 13(2), 102–108. https://doi.org/10.1136/neurintsurg-2020-016862
5. Mitchell, P., Lee, S. C. M., Yoo, P. E., Morokoff, A., Sharma, R. P., Williams, D. L., MacIsaac, C., Howard, M. E., Irving, L., Vrljic, I., Williams, C., Bush, S., Balabanski, A. H., Drummond, K. J., Desmond, P., Weber, D. P., Denison, T., Mathers, S., O'Brien, T. J., Mocco, J., Grayden, D. B., Liebeskind, D. S., Opie, N. L., Oxley, T. J., & Campbell, B. C. V. (2023). Assessment of safety of a fully implanted endovascular brain-computer interface for severe paralysis in 4 patients: the Stentrode With Thought-Controlled Digital Switch (SWITCH) study. JAMA Neurology, 80(3), 270–278. https://doi.org/10.1001/jamaneurol.2022.4847